Genomill Health

Private

TurkuHealthcare & Life Scienceshttps://genomill.com/

Last Round

VC Round

Sep 14, 2023

Total Funding Raised

$390,000

Company Overview

Genomill Health is a biotechnology company that develops precision diagnostics technology designed to improve the accessibility and efficiency of liquid biopsies for cancer diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

liquid biopsyNGSNext-Generation SequencingNGS sample prepmolecular diagnosticsNGS library prepcancer diagnosticsprecision oncologytechnology licensingMinimal Residual Disease monitoringMRD monitoringtargeted NGSclinical diagnosticsbioinformaticssequencing technologyinfectious disease detectionpre-natal care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomill Health Comps

Public and private peers based on sector, stage, and business model.

Genomill Health comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Genomill Health Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Sep 14, 2023
Seed	Dec 19, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Manu Tamminen

CEO, Co-founder

Founding Team

Juha-Pekka Pursiheimo

Chief Technology Officer

Executive Team

Erno Sundberg

Chief Operating Officer

Executive Team

Genomill Health Investors

Notable investors and investment history

Genomill Health investors
Investor	Rounds
SPARK Finland	Accelerator
Business Finland	Grant
Voima Ventures	Seed
Avohoidon Tutkimussäätiö	Seed
Almaral	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 3, 2026
Monthly visitors increased 185% MoM.
Jul 5, 2025
Monthly visitors increased 494% MoM.

View all signals

Genomill Health Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Genomill Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genomill Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersTurku

Employee Range14

Year Founded2018

Last FundingSep 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.